" class="no-js "lang="en-US"> VectorBuilder - Medtech Alert
Tuesday, September 30, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
VectorBuilder | Pharmtech Focus

VectorBuilder

About VectorBuilder

VectorBuilder

VectorBuilder is a rapidly growing biotechnology company that has established itself as a global leader in a range of life sciences products and services, including vector cloning, virus packaging, library construction, stable cell line generation, CAR-T technology, COVID-19 research reagents, and GMP manufacturing of clinical grade plasmid DNA and viruses. VectorBuilder’s revolutionary online vector design platform has become highly popular with researchers around the world for its rich functionalities and highly intuitive user interface.

Related Story

Diseases

 Univercells Technologies and VectorBuilder Announce Strategic Partnership for Optimized Custom Viral Vector Production | Pharmtech Focus

Univercells Technologies and VectorBuilder Announce Strategic Partnership for Optimized Custom Viral Vector Production

July 7 2021

Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production, has […]